Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC7A1 |
| Upstream (Parents) |
|---|
| (<<) FAM60A → SLC7A1 |
| (<<) MYB → SLC7A1 |
| Downstream (Children) |
|---|
| SLC7A1 → ZMYM2 (>>) |
| SLC7A1 → C13orf23 (>>) |
| SLC7A1 → FAM60A (>>) |
| SLC7A1 → SLC25A36 (>>) |
| SLC7A1 → MYB (>>) |
| SLC7A1 → LGR5 (>>) |
| SLC7A1 → HOXA10 (>>) |
| SLC7A1 → MKI67 (>>) |
| SLC7A1 → ASNS (>>) |
| SLC7A1 → ITPR3 (>>) |
| SLC7A1 → OSBPL3 (>>) |
| SLC7A1 → POLR1D (>>) |
| SLC7A1 → WHSC1 (>>) |
| SLC7A1 → GNA14 (>>) |
| SLC7A1 → GON4L (>>) |
| SLC7A1 → FBXO41 (>>) |
| SLC7A1 → CTTN (>>) |
| SLC7A1 → IGSF3 (>>) |
